Industry

New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Genentech’s Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A

– Hemlibra continues to demonstrate clinically meaningful bleed control, with 66.7% of participants with moderate or mild hemophilia A experiencing zero treated bleeds at 55.6 weeks median follow-up – – New data also reinforce Hemlibra’s favorable safety profile, with no new safety signals observed – – There is limited information and treatment guidance on moderate … [Read more…]

Thermo Fisher Scientific Launches CE-IVD Marked TaqPath Respiratory Viral Select Panel

The PCR assay panel tests for five respiratory viruses in under three hours CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Applied Biosystems TaqPath Respiratory Viral Select Panel; a CE-IVD-marked molecular assay panel for detection of five common viruses, including those that cause the common cold, … [Read more…]

KA Imaging’s Reveal 35C Images Shown to Increase Lung Lesion Visibility

Initial Results from Clinical Trial on Lung Lesion Detection Will be Presented at ECR 2022 WATERLOO, Ontario–(BUSINESS WIRE)–#ECR2020–KA Imaging, a company that develops innovative X-ray imaging solutions, announced the initial results from a study examining the diagnostic value of single-exposure dual-energy subtraction radiography in lung lesion detection. In the study, a radiologist blinded to standard-of-care … [Read more…]

Deenova Continues Its Innovation Streak With the Unveiling of the Next Generation of ALL-IN-1, its Cutting-Edge All Medication Forms Unit Dose Repackaging Robot

MILAN–(BUSINESS WIRE)–Following its previous announcements in March 2022, for the release of three new innovative additions to its award winning D3 product line of mechatronic solutions, Deenova further consolidates its technological leadership in the field of pharmacy automation, and announced today the unveiling of the second generation of its ALL-IN-1 robot, able to automatically repack … [Read more…]

BGI’s Huo-Yan Lab Helps Saudi Arabia to Safeguard Pilgrims’ Health During the Hajj

RIYADH, Saudi Arabia–(BUSINESS WIRE)–In the early morning of July 4, in response to the needs of the Saudi Arabian National Public Health Authority, BGI’s Huo-Yan Cube laboratory was successfully delivered to Mecca to help strengthen the COVID-19 control and prevention. During the annual Hajj, nearly a million pilgrims will travel to Mecca. The addition of … [Read more…]

Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders

PALO ALTO, Calif.–(BUSINESS WIRE)–Social Capital Suvretta Holdings Corp. III (“SCS”) today announced that it will reconvene the Extraordinary General Meeting of its shareholders to vote on the Business Combination Agreement, dated as of January 18, 2022, by and between SCS and ProKidney LP, a limited partnership organized under the laws of Ireland (“ProKidney”), acting through … [Read more…]

The Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP) Hosted the Inaugural @Philly Cell and Gene Therapy Annual Conference

PHILADELPHIA–(BUSINESS WIRE)–The Inaugural @Philly Cell and Gene Therapy Annual Conference (https://atphilly.org/) was held on June 17-18 at the Sheraton Valley Forge Hotel northwest of Philadelphia. Organized by the Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP. https://sapagp.org/), the conference was sponsored by twenty-nine companies. Over five-hundred life scientists, pharmaceutical professionals, and business executives attended the conference. For … [Read more…]

Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region

CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that the results of the pivotal Phase II of its Investigational Device Exemption (“IDE”) study evaluating the safety and effectiveness of the Renuvion device to improve the appearance of lax … [Read more…]

AESARA to welcome the incoming class of five fellows and a visiting scientist.

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)–#Europe–AESARA is pleased to announce the new entrants to its two-year Doctor of Pharmacy fellowship program, Denise Garner, PharmD, Ashik Jayakumar, PharmD, Fadi Manuel, PharmD and Amanda Pan, PharmD. Denise and Ashik are joining AESARA as part of the Market Access and Health Informatics Fellowship … [Read more…]

Global Surgical Site Infection Control Market Report (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Surgical Site Infection Control Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global surgical site infection control market reached a value of US$ 4.20 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 5.51 Billion … [Read more…]